ROCHE TO ACQUIRE REST OF FOUNDATION MEDICINE

Roche has agreed to pay $2.4 billion to acquire the part of Cambridge, Massachusetts-based Foundation Medicine that the Swiss drugmaker does not already own. The deal is scheduled to wrap up in the second half of 2018 and represents a total company value of $5.3 billion on a fully diluted basis.